SecBot SecBot
SECBOTREPLAY Home › Report › ELV

ELV · Two Elevance Health insiders, including CEO Gail Boudreaux, made…

Elevance Health, Inc. · CLUSTER filed Jul 17, 2026 at 15:04 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jul 17, 2026 at 15:04 ET

Two Elevance Health insiders, including CEO Gail Boudreaux, made open-market purchases totaling $1.37M over two days following the Q2 2026 earnings release. The CEO bought $1.0M worth of shares, and a director bought $366K. However, the total purchase amount represents only ~0.0017% of ELV's $81B market cap, making it a trivial signal.

  • CEO Gail Boudreaux purchased 2,725 shares at ~$367.50 avg, totaling $1,002,230
  • Director Ramiro G. Peru purchased 1,000 shares at $366.05, totaling $366,050
  • Total insider purchases: $1,368,280, or 0.0017% of $81B market cap
  • Purchases occurred 2 days after Q2 2026 earnings (EPS beat by 20%, but revenue growth flat and margins compressed)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access